Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs
IntroductionIncreased de novo lipogenesis (DNL) is one of the key factors contributing to fat accumulation and non-alcoholic fatty liver disease (NAFLD). Among the critical transcription factors (TFs) regulating DNL is mTOR and its downstream lipogenic TF, SREBP1c. In recent years, it has been estab...
Main Authors: | Shereen A. El Sobky, Nourhan K. Aboud, Nihal M. El Assaly, Injie O. Fawzy, Nada El-Ekiaby, Ahmed I. Abdelaziz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.903856/full |
Similar Items
-
SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies
by: Na Li, et al.
Published: (2023-12-01) -
Dexamethasone potentiates the insulin-induced Srebp-1c expression in primary rat hepatocytes
by: Yan Zhang, et al.
Published: (2023-09-01) -
The role of KLF2 in regulating hepatic lipogenesis and blood cholesterol homeostasis via the SCAP/SREBP pathway
by: Yuhong Huang, et al.
Published: (2024-01-01) -
Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila
by: Xiao Li, et al.
Published: (2022-11-01) -
In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions
by: Zhixian Zhu, et al.
Published: (2023-12-01)